Measurable Residual Disease in Pediatric Acute Leukemia: Application and Interpretation of Current and Emerging Methodologies.

Eidenschink Brodersen L, Kovach AE, Zuna J

Open source

DOI
10.1200/edbk-26-516962
Published
2026 Jun
Container
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/edbk-26-516962,
  title = {Measurable Residual Disease in Pediatric Acute Leukemia: Application and Interpretation of Current and Emerging Methodologies.},
  author = {Eidenschink Brodersen L and Kovach AE and Zuna J},
  year = {2026},
  journal = {American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting},
  doi = {10.1200/edbk-26-516962},
  url = {https://doi.org/10.1200/edbk-26-516962}
}

RIS

TY  - JOUR
TI  - Measurable Residual Disease in Pediatric Acute Leukemia: Application and Interpretation of Current and Emerging Methodologies.
AU  - Eidenschink Brodersen L
AU  - Kovach AE
AU  - Zuna J
PY  - 2026
JO  - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
DO  - 10.1200/edbk-26-516962
UR  - https://doi.org/10.1200/edbk-26-516962
ER  - 

APA

L, E. B., AE, K., & J, Z. (2026). Measurable Residual Disease in Pediatric Acute Leukemia: Application and Interpretation of Current and Emerging Methodologies.. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. https://doi.org/10.1200/edbk-26-516962

Source records